Table 3.
Drugs classes used continuously by patients hospitalized with COVID-19.
| Drug class | Overall n = 147 | Hospital discares n = 133 | Deaths n = 14 | p-value | Relative Risk (CI 95%) |
|---|---|---|---|---|---|
| Adrenergic blocker | 18 | 16 | 2 | 0.6858 | 1.176 (0.3024–4.015) |
| Non-steroidal anti-inflammatory | 19 | 15 | 4 | 0.0644 | 2.716 (0.9451–7.092) |
| Angiotensin II receptor antagonists | 41 | 36 | 5 | 0.5354 | 1.436 (0.5242–3.799) |
| ACE inhibitors | 15 | 13 | 1 | 0.6373 | 1.467 (0.3783–4.875) |
| Calcium channel blocker | 22 | 18 | 4 | 0.1261 | 2.309 (0.7998–6.134) |
| Anticholesterolemic | 28 | 22 | 6 | *0.0171 | 3.188 (1.215–7.997) |
| Diuretic | 20 | 14 | 6 | *0.0007 | 4.800 (1.853–11.67) |
| Hypoglycemic | 30 | 26 | 4 | 0.4853 | 1.560 (0.5367–4.267) |
| Psychotropics | 18 | 15 | 3 | 0.3814 | 1.955 (0.6098–5.581) |
Data are presented as relative risk and confidence intervals (CIs) 95%.
A two-tailed p-value of ≤ 0.05 was considered significant. Bold values and (*) show significant diferences.